NCT06651840

Brief Summary

The aim of this study is to compare the outcomes of coblation technique versus bipolar technique in management of RAE in children regarding the following:

  1. 1.Efficacy of each method to stop bleeding.
  2. 2.Technical feasibility.
  3. 3.Mucosal healing and crust formation.
  4. 4.Post operative complications like: synechia formation and septal perforation.
  5. 5.Nostril stenosis/ atresia.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2025

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 19, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 22, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

March 1, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

February 19, 2025

Status Verified

February 1, 2025

Enrollment Period

9 months

First QC Date

October 19, 2024

Last Update Submit

February 15, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of participants with successful hemostasis on the day of the procedure.

    No epistaxis within the first 24 hours of the procedure.

    The first 24 hours postoperative

Secondary Outcomes (1)

  • Postoperative complications

    6 months

Study Arms (2)

Group A: patients in this group will be managed with bipolar diathermy "Standard technique".

ACTIVE COMPARATOR

The bipolar technique for group A: A bipolar with straight blade will be used with a footplate-operated switch to control the coagulation time, and the length, width and depth of penetration of the thermal power. The lesion will be coagulated in a distal-to-proximal direction to achieve a uniform gray-white coagulation zone in the lesion and surrounding tissue. Multiple ablations at the same area should be avoided to avoid septal perforation. After finishing coagulation small gauze impregnated with antibiotic ointment will be applied for 2 hours postoperatively.

Procedure: bipolar diathermy "Standard technique".

Group B: patients in this group will be managed with coblation technique.

EXPERIMENTAL

The coblation technique for group B: An coblator with tonsillar blade will be used with a footplate-operated switch to control the coagulation time, and the length, width and depth of penetration of the thermal power. The lesion will be coagulated in a distal-to-proximal direction to achieve a uniform gray-white coagulation zone in the lesion and surrounding tissue. Multiple ablations at the same area should be avoided to avoid septal perforation. After finishing coagulation small gauze impregnated with antibiotic ointment will be applied for 2 hours postoperatively.

Procedure: coblation technique.

Interventions

The bipolar technique for group A: A bipolar with straight blade will be used with a footplate-operated switch to control the coagulation time, and the length, width and depth of penetration of the thermal power. The lesion will be coagulated in a distal-to-proximal direction to achieve a uniform gray-white coagulation zone in the lesion and surrounding tissue. Multiple ablations at the same area should be avoided to avoid septal perforation. After finishing coagulation small gauze impregnated with antibiotic ointment will be applied for 2 hours postoperatively.

Group A: patients in this group will be managed with bipolar diathermy "Standard technique".

The coblation technique for group B: An coblator with tonsillar blade will be used with a footplate-operated switch to control the coagulation time, and the length, width and depth of penetration of the thermal power. The lesion will be coagulated in a distal-to-proximal direction to achieve a uniform gray-white coagulation zone in the lesion and surrounding tissue. Multiple ablations at the same area should be avoided to avoid septal perforation. After finishing coagulation small gauze impregnated with antibiotic ointment will be applied for 2 hours postoperatively.

Group B: patients in this group will be managed with coblation technique.

Eligibility Criteria

Age6 Years - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • A history of repeated unilateral epistaxis with at least four episodes, at least one episode per week during the preceding 4 weeks.
  • Age \> 5 years of age and \< 18 years of age.
  • Failure of topical treatment with an antiseptic ointment, with or without silver nitrate cautery.
  • A Katsanis epistaxis scoring system (ESS) score of 7-10.
  • Bleeding originating from Kiesselbach's plexus, located in the anteroinferior portion of the nasal septum.

You may not qualify if:

  • Patients \< 5 years of age and \>= 18 years of age.
  • Patients with bilateral epistaxis.
  • Patients with bleeding tendencies like: Hemophilia, Leukemia, Idiopathic thrombocytopenic purpura, Von Willebrand disease and Thrombasthenia.
  • Patients with previous nasal surgeries.
  • Patients with hereditary hemorrhagic telangiectasia.
  • Patients with vascular lesions like: angiofibroma, pyogenic granuloma and bleeding polypus.
  • Patients who are unfit for surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Lou ZC. Hemostasis of idiopathic recurrent epistaxis in children with microwave ablation: a prospective pilot case series. J Otolaryngol Head Neck Surg. 2019 Dec 18;48(1):72. doi: 10.1186/s40463-019-0393-0.

    PMID: 31852515BACKGROUND

Study Officials

  • Aly R Selim, Professor

    Professor

    STUDY CHAIR
  • Shimaa I Abdallah, Ass.Prof

    Assistant Professor

    STUDY DIRECTOR

Central Study Contacts

Abanoub H Mejalli

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

October 19, 2024

First Posted

October 22, 2024

Study Start

March 1, 2025

Primary Completion

December 1, 2025

Study Completion

January 1, 2026

Last Updated

February 19, 2025

Record last verified: 2025-02